Narrative review / 2008
AMP-activated protein kinase regulates energy metabolism, with altered activity noted in obesity, type 2 diabetes, and cardiovascular disease.
This review discusses the role of AMP-activated protein kinase (AMPK) as a key regulator of energy metabolism, fatty acid and glucose metabolism, and appetite. Alterations in AMPK activity have been reported in obesity, type 2 diabetes, the metabolic syndrome, and cardiovascular disease. The authors note it remains debated whether AMPK changes are a cause or a consequence of these conditions, though it represents a potential pharmacological target.
- Study type
- Narrative review
- Who was studied
- Not specified (review of genetic, obesity models, and human studies)
- What was measured
- Role of AMPK in energy metabolism, obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease
THE PAPER
The role of AMP-activated protein kinase in obesity.
Kola B, Grossman AB, Korbonits M. Front Horm Res, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.